Inventor
GUENZLER-PUKALL VOLKMAR
DE34 patents
⚠️ This page may combine multiple inventors who share the name “GUENZLER-PUKALL VOLKMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FIBROGEN INC
17 patentsUS7323475B2Jan 29, 2008
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC97 citations98
US7863292B2Jan 4, 2011
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC28 citations96
US7629357B2Dec 8, 2009
Nitrogen-containing heteroaryl compounds and methods of user thereof
FIBROGEN INC38 citations96
US8017625B2Sep 13, 2011
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC42 citations94
US9920011B2Mar 20, 2018
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC10 citations92
US9339527B2May 17, 2016
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC7 citations92
US8765956B2Jul 1, 2014
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC19 citations92
US7618940B2Nov 17, 2009
Fat regulation
FIBROGEN INC35 citations90
US10894774B2Jan 19, 2021
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC3 citations84
US10882827B2Jan 5, 2021
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC3 citations84
US10626090B2Apr 21, 2020
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC6 citations84
US10092558B2Oct 9, 2018
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC3 citations84
US10927081B2Feb 23, 2021
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC3 citations83
US11680048B2Jun 20, 2023
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC1 citations73
US11680047B2Jun 20, 2023
Enhanced erythropoiesis and iron metabolism
FIBROGEN INC1 citations72
US11229637B2Jan 25, 2022
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC0 citations62
US10646482B2May 12, 2020
Nitrogen-containing heteroaryl compounds and methods of use thereof
FIBROGEN INC0 citations52
HOECHST AG
7 patentsUS5519038AMay 21, 1996
N,N'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamines
HOECHST AG21 citations92
US5260323ANov 9, 1993
2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
HOECHST AG54 citations92
US5130317AJul 14, 1992
Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use thereof, and pharmaceuticals based on these compounds
HOECHST AG32 citations92
US5204338AApr 20, 1993
Oxalylamino acid derivatives and their use as medicaments for inhibiting proline hydroxylase
HOECHST AG22 citations91
US5428046AJun 27, 1995
Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments
HOECHST AG2 citations52
US5240921AAug 31, 1993
Cyclic pyridine-2,4- and -2,5-dicarboxylic acid diamides, processes for their preparation and their use
HOECHST AG1 citations52
US5482953AJan 9, 1996
2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharmaceuticals
HOECHST AG0 citations51
KLAUS STEPHEN J
5 patentsUS8629131B2Jan 14, 2014
Enhanced erythropoiesis and iron metabolism
KLAUS STEPHEN J10 citations92
US8614204B2Dec 24, 2013
Enhanced erythropoiesis and iron metabolism
KLAUS STEPHEN J8 citations92
US8609646B2Dec 17, 2013
Enhanced erythropoiesis and iron metabolism
KLAUS STEPHEN J10 citations92
US8604012B2Dec 10, 2013
Enhanced erythropoiesis and iron metabolism
KLAUS STEPHEN J10 citations92
US8604013B2Dec 10, 2013
Enhanced erythropoiesis and iron metabolism
KLAUS STEPHEN J6 citations83